Differential gene expression downstream of Toll-like receptors (TLRs): role of c-Src and activating transcription factor 3 (ATF3)
Department of Medicine, Division of Infectious Diseases and Immunology
Activating Transcription Factor 3; Animals; Cell Line; CpG Islands; Humans; Interferon Regulatory Factor-3; Interferon Regulatory Factors; Interleukin-6; Mice; Models, Biological; Protein-Tyrosine Kinases; RNA Interference; Signal Transduction; Toll-Like Receptors
Interferon regulatory factors (IRFs) are crucial for transcription during innate immune responses. We have previously shown that the tyrosine kinase c-Src enhances IRF-3-dependent transcription in response to viral double-stranded RNA. In this study, we show that c-Src has distinct roles in Toll-like receptor (TLR)-mediated activation of IRF-5 and IRF-3. Surprisingly, c-Src inhibition markedly enhanced IRF-5 activation after treatment with unmethylated CpG, while suppressing IRF-3 activation. Also, CpG-elicited interleukin-6 mRNA production was increased, whereas IP10 mRNA synthesis was reduced in cells deficient in c-Src. Interestingly, c-Src regulated TLR-stimulated induction of activating transcription factor 3 (ATF3), a transcriptional repressor. Depletion of ATF3 by small interfering RNA markedly enhanced interleukin-6 production after CpG treatment, whereas IP10 production was reduced. These results demonstrate functional specificity for c-Src in TLR-stimulated responses and suggest that c-Src modulation and ATF3 activity may contribute to differential regulation of IRF-3- versus IRF-5-mediated gene expression.
Rights and Permissions
Citation: J Biol Chem. 2010 May 28;285(22):17011-9. Epub 2010 Mar 29. Link to article on publisher's site
Nguyen, Thuy Thanh; Johnsen, Ingvild B.; Knetter, Catherine F.; Drablos, Finn; Fitzgerald, Katherine A.; Lien, Egil; and Anthonsen, Marit W., "Differential gene expression downstream of Toll-like receptors (TLRs): role of c-Src and activating transcription factor 3 (ATF3)" (2010). Infectious Diseases and Immunology Publications and Presentations. 52.